Stocks › ALMS
ALUMIS INC.
ALMS·Nasdaq·
United States·USD
United States·USD$6.93
+0.09 (+1.32%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
ALMS
ALUMIS INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ALMSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of ALMS by members of U.S. Congress · 0 on record
No congressional trades in ALMS on record.
Whale Activity
Position changes in ALMS reported for 2026-06-30 by 11 tracked institutional filers
- Increased5
- New0
- Held0
- Decreased2
- Closed2
- No prior filing2
| Filer | Shares | Value | Change |
|---|---|---|---|
| AyurMaya Capital Management Company, LP | 15.1M | $426.0M | — |
| BlackRock, Inc. | 8.2M | $231.3M | increased |
| venBio Partners LLC | 4.5M | $127.4M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2M | $118.6M | increased |
| D. E. Shaw & Co., Inc. | 968.2K | $27.2M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 921.2K | $25.9M | increased |
| MILLENNIUM MANAGEMENT LLC | 660.1K | $18.6M | increased |
| TWO SIGMA INVESTMENTS, LP | 376.1K | $10.6M | decreased |
| RENAISSANCE TECHNOLOGIES LLC | 23.3K | $657K | decreased |
| Point72 Asset Management | 0 | $0 | closed |
| Citadel Advisors LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by ALMS insiders, by quarter · Form 4
Recent Insider Transactions
161 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| AKKARAJU SRINIVASDirector · Director | Sale | −48.1K | $10.55 | $507K | Sep 8, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Sale | −48.1K | $10.55 | $507K | Sep 8, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +273.3K | $10.63 | $2.9M | Sep 8, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +273.3K | $10.63 | $2.9M | Sep 8, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +220.1K | $11.17 | $2.5M | Sep 4, 2026 | Form 4 ↗ |
| AKKARAJU SRINIVASDirector · Director | Purchase | +220.1K | $11.17 | $2.5M | Sep 4, 2026 | Form 4 ↗ |
| Pangali SanamChief Legal Officer | Sale | −1,364 | $26.37 | $36K | Aug 3, 2026 | Form 4 ↗ |
| Bradley Mark ChristopherChief Development Officer | Sale | −2,572 | $26.37 | $68K | Aug 3, 2026 | Form 4 ↗ |
| Drappa JornChief Medical Officer | Sale | −2,447 | $26.37 | $65K | Aug 3, 2026 | Form 4 ↗ |
| Goldstein David MChief Scientific Officer | Sale | −2,596 | $26.37 | $68K | Aug 3, 2026 | Form 4 ↗ |
| Schroer John R.Chief Financial Officer | Sale | −3,282 | $26.37 | $87K | Aug 3, 2026 | Form 4 ↗ |
| Hardiman Roy C.Chief Business & Strategy Ofcr | Sale | −2,692 | $26.37 | $71K | Aug 3, 2026 | Form 4 ↗ |
| Pangali SanamChief Legal Officer | Sale | −5,000 | $28.00 | $140K | Jul 6, 2026 | Form 4 ↗ |
| Drappa JornChief Medical Officer | Option exercise | +15.5K | $5.06 | $79K | May 22, 2026 | Form 4 ↗ |
| Drappa JornChief Medical Officer | Option exercise | +11.3K | $8.84 | $100K | May 22, 2026 | Form 4 ↗ |
| Foresite Labs Affiliates 2021, LLC10% owner | Other | +680.5K | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Foresite Labs Affiliates 2021, LLC10% owner | Other | −1.1M | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Foresite Labs Affiliates 2021, LLC10% owner | Other | +1.1M | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Foresite Labs Affiliates 2021, LLC10% owner | Other | −1.2M | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
| Foresite Capital Management VI LLC10% owner | Other | +680.5K | $0.00 | $0 | Apr 1, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding ALMS · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3.1M | $88.4M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 2.0M | $56.9M | 0.07% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 1.4M | $38.5M | 0.26% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 1.1M | $31.2M | 0.35% | Jul 31, 2026 |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 1.1M | $31.2M | 0.42% | Jul 31, 2026 |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 1.1M | $30.6M | 0.31% | Jun 30, 2026 |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 977.1K | $27.5M | 0.03% | Jun 30, 2026 |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 946.5K | $26.7M | 1.22% | Jul 31, 2026 |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 863.9K | $24.4M | 0.07% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF iShares Trust | 682.0K | $19.2M | 0.12% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list ALMS's shares (CUSIP 022307102), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- James B. TananbaumSCHEDULE 13D · activist (13D) · 9.2M shares14.5%
Aug 17, 2026 · ↗ - Foresite Capital Opportunity Management V, LLCSCHEDULE 13D · activist (13D) · 3.4M shares5.4%
Aug 17, 2026 · ↗ - Foresite Capital Opportunity Fund V, L.P.SCHEDULE 13D · activist (13D) · 3.4M shares5.4%
Aug 17, 2026 · ↗ - Foresite Capital Management V, LLCSCHEDULE 13D · activist (13D) · 3.6M shares5.6%
Aug 17, 2026 · ↗ - Foresite Capital Fund V, L.P.SCHEDULE 13D · activist (13D) · 3.6M shares5.6%
Aug 17, 2026 · ↗ - Foresite Capital Management VI, LLCSCHEDULE 13D · activist (13D) · 2.2M shares3.5%
Aug 17, 2026 · ↗ - Foresite Capital Fund VI LPSCHEDULE 13D · activist (13D) · 2.2M shares3.5%
Aug 17, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 6.8M shares5.5%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G · passive (13G) · 6.8M shares5.5%
Aug 6, 2026 · ↗ - BlackRock, Inc.SCHEDULE 13G · passive (13G) · 7.1M shares5.7%
Jul 27, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming ALUMIS INC. as client
No lobbying filings found naming ALUMIS INC. as the client.
Government Contracts
Federal awards to ALUMIS INC. · USAspending
No federal contract awards found for ALUMIS INC..
U.S. Patents
Recent USPTO applications naming ALUMIS INC.
No USPTO patent applications found for ALUMIS INC..
Annual Financials
From ALMS's 10-K filings · XBRL
No annual XBRL figures on record for ALMS. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in ALMS's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 8.01, 9.01Other eventsSep 1, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 13, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsAug 10, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJul 2, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsJun 29, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 14, 2026
EDGAR ↗
About ALUMIS INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersSOUTH SAN FRANCISCO, CA
IncorporatedDE
SEC CIK0001847367 ↗
Former namesFL2021-001, Inc.